Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Cancers
•
Pediatric Hematology/Oncology
•
FAQ
•
Medical Oncology
Is there a Mednet app?
Answer from: Radiation Oncologist at Community Practice
theMednet app is here! Follow these links to download it for your iOS and Android devices.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
As more hospitals improve their WiFi, I envision attendings and residents co-reviewing comments from themednet in between patient visits. Looking forward to it.
Sign in or Register to read more
1158
1166
Related Questions
What are your top takeaways from SGO 2024?
What are your top takeaways in Gyn Cancers from ASCO 2024?
How would you sequence adjuvant chemo-immunotherapy (paclitaxel/carbo/pembro or paclitaxel/carbo/dostarlimab) with EBRT and vaginal cuff brachytherapy in advanced uterine cancer that meets clinical criteria for both EBRT and chemo-IO?
How would you manage a POLE mutated, p53 abnormal IA myoinvasive carcinosarcoma of the endometrium with no LVSI?
How do you approach a young patient with metastatic poorly differentiated thyroid cancer with rhabdoid/non-anaplastic features?
For a patient with IIIC1 (micromets), MSI-high, Grade 2 endometrial adenocarcinoma who has undergone full surgical staging, do you recommend adding immunotherapy to adjuvant chemotherapy + radiation?
How would you manage a cervical cancer patient with bulky PA LNs with direct extension and/or invasion into the lumbar vertebral bodies?
Given the negative results of GOG-0238 but the positive results of the RUBY trial, how do you manage isolated vaginal cuff recurrence of endometrial cancer?
Would you recommend surgery or stereotactic radiation therapy for a young woman with high-grade serous ovarian cancer presenting with a pelvic LN oligometastasis following maintenance therapy?
How would you approach patients with primary cardiac sarcomas for adjuvant systemic treatment?